The side effects of avatrombopag on renal function

Avatrombopag is a drug used to treat certain types of thrombocytopenia, especially chronic immune thrombocytopenia (ITP). Although it is very effective in increasing platelet count, it can also cause some side effects, one of which is an effect on kidney function.

In clinical research and practice, there have been reports of occasional renal dysfunction during use of avatrombopag. This may manifest as mild to moderate renal impairment, such as decreased glomerular filtration rate (GFR) or impaired tubular function. This abnormality in kidney function is usually temporary, and severe kidney damage rarely occurs.

Avatrombopag may affect renal function through multiple mechanisms. These include effects on renal hemodynamics, as well as direct effects on renal tubules. These effects may lead to decreased glomerular filtration rate, changes in urine composition, and abnormalities in other renal function parameters.

Use avatrombopag with extreme caution in patients with known renal dysfunction. In these cases, doctors may monitor patients' kidney function more frequently and use the results to decide whether to adjust medication doses or implement other interventions.

In addition, for patients with underlying poor renal function, it is recommended that doctors evaluate the patient's renal function status in detail before starting treatment and regularly monitor renal function during treatment. This helps detect and manage any potential kidney damage early to reduce adverse effects.

Overall, although avatrombopag may have some effects on renal function, these effects are usually mild and reversible. When using this drug, doctors should pay close attention to the patient's renal function and take appropriate monitoring and management measures as needed to ensure patient safety and good therapeutic effects.